On the upside
Vivendi SA (NYSE: VIV) reported lower 1st half revenues and profits as the media and entertainment company weathered the global downturn.
Bank of America (NYSE: BAC) announced plans to re-pay some of the $45 billion in TARP funds that the company had received from the federal bailout.
Novavax (Nasdaq: NVAX) reported positive clinical trial results that met safety goals for its flu vaccine candidate.
On the downside
CardioNet (Nasdaq: BEAT) revealed that Highmark Medicare Services will implement a reduced reimbursement schedule for mobile cardiac services.
Shares of China Medical Technologies (Nasdaq: CMED) fell after the company posted higher revenues and lower income versus year-ago levels.
An analyst downgraded American Axle & Manufacturing Holdings (NYSE: AXL) due to valuation. Last month, the auto parts maker reached a deal with General Motors for a $110 million cash infusion and a $100 million loan facility.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by more than 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks added 3 points to 575.
